Kevin K. Gordon
Kevin K. Gordon
Kevin K. Gordon joined the Veracyte board of directors in December 2016. Mr. Gordon has served as President and Chief Financial Officer of Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, since January 2018. Prior to that, Mr. Gordon served as Executive Vice President and Chief Operating Officer of Quintiles Transnational Holdings Inc., a research, clinical trial and pharmaceutical consulting company, from October 2015 until October 2016 and served as Executive Vice President and Chief Financial Officer from July 2010 to December 2015 (Quintiles Transitional Holdings merged with IMS Health Holdings, Inc., an information and technology services company, in October 2016 to form IQVIA Holdings, Inc., a global biopharmaceutical services provider). Prior to that, Mr. Gordon spent 13 years in senior leadership positions at Teleflex Incorporated, a diversified global company with over $2 billion in annual revenue, where he served as Executive Vice President and CFO from March 2007 to January 2010. From 1992 to 1997, he held various senior positions, including Chief Financial Officer at Package Machinery Company, a consumer product packaging equipment company. He previously held senior management positions at KPMG. Mr. Gordon currently serves on the board of directors of Progyny, Inc., a fertility benefits management company, since October 2019 and Q Holdco Limited, a private company that provides engineered and elastomeric solutions, since September 2019. He holds a B.S. in Accounting from the University of Connecticut.